期刊文献+

OPN与AL患者临床特征及预后的关系 被引量:1

Correlations of osteopontin with clinical characteristics and prognosis of primary systemic amyloidosis
下载PDF
导出
摘要 目的探讨骨桥蛋白(OPN)与原发性系统性淀粉样变(AL)临床特征及预后的关系。方法选择2005年3月-2015年3月于佛山市中医院检验医学中心就诊的原发性系统性淀粉样变患者60例作为AL组,分析不同临床特征之间的OPN水平。选择同期在该院进行健康查体者60例作为对照组,检测两组研究对象OPN水平和肌钙蛋白t(c Tn T)水平,分析OPN水平与c Tn T水平的相关性。并检测AL组经自体干细胞移植术治疗后不同预后患者OPN和c Tn T水平。结果 OPN水平在AL患者中不同肾小球滤过率、受累器官数、纽约心脏病协会心功能分级、二尖瓣环收缩速度、射血分数、心肌质量指数及左心房直径之间比较,差异有统计学意义(P<0.05)。AL组OPN和c Tn T的水平均高于对照组的水平(P<0.05),且OPN水平与c Tn T的水平呈正相关(P<0.05)。结论 OPN水平与AL临床特征及预后有关,在AL的诊断及预后评估中具有重要的临床价值。 Objective To investigate the correlations of serum osteopontin(OPN)level with clinical characteristics and prognosis of primary systemic amyloidosis(AL).Methods In this study,60patients with AL(AL group)treated in our hospital between March2005and March2015were enrolled.The OPN levels in the AL patients with different clinical features were analyzed.Meanwhile,60healthy subjects having health examination during the same period were selected as the control group.The levels of OPN and troponin t(cTnT)in the two groups were compared.Also,the correlation analysis between OPN level and cTnT level was conducted.After autologous stem cell transplantation,the levels of OPN and cTnT in the AL patients with different prognosis were detected.Results The OPN levels were significantly different in the AL patients with different glomerular filtration rate,number of organs involved,NYHA(New York Heart Association)classification grade of heart function,speed of mitral annular contraction,ejection fraction,cardiac mass index and diameter of left atrium(P<0.05).The levels of OPN and cTnT in the AL group were higher than those in the control group(P<0.05).Moreover,the OPN level showed a positive correlation with cTnT level(P<0.05).Conclusions The level of OPN is related to the clinical characteristics and prognosis of primary systemic amyloidosis,and has important clinical value in the diagnosis and prognostic evaluation of the disease.
作者 陈玉祯 谭雪红 卓雪芽 叶桂样 黄声淳 陈胜男 谭顺莲 Yu-zhen Chen;Xue-hong Tan;Xue-ya Zhuo;Gui-yang Ye;Sheng-chun Huang;Sheng-nan Chen;Shun-lian Tan(Laboratory Medicine Center, Foshan Hospital of Traditional Chinese Medicine, Foshan,Guangdong 528000, China)
出处 《中国现代医学杂志》 CAS 2018年第2期113-116,共4页 China Journal of Modern Medicine
关键词 骨桥蛋白 肌钙蛋白 原发性系统性淀粉样变 osteopontin cardiac troponin t primary systemic light-chain amyloidosis
  • 相关文献

参考文献5

二级参考文献58

  • 1Kyle RA, Greipp PR. Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo. Blood, 1978, 52: 818-827.
  • 2Comenzo RL, Vosburgh E, Simms RW, et al. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. Blood, 1996, 88 : 2801-2806.
  • 3Abraham RS, Katzmann JA, Clark R J, et al. Quantitative analy- sis of serum free light chains : a new marker for the diagnostic eval- uation of primary systemie amyloidosis. Am J Clin Pathol, 2003, 119 : 274-278.
  • 4Gertz MA, Kyle RA, Greipp PR. Response rates and survival in primary systemc amyloidosis. Blood, 1991, 77 : 257-262.
  • 5Kyle RA, Gertz MA, Greipp PR, et al. Long-term survival (10 years or more) in 30 patients with primary amyloidosis. Blood, 1999, 93 : 1062-1066.
  • 6Comenzo RL, Vosburgh E, Falk RH, et al. Dose-intensive mel- phalan with blood stem-cell support for the treatment of AL ( amy- loid light-chain ) amyloidosis: survival and responses in 25 pa- tients. Blood, 1998, 91: 3662-3670.
  • 7Dispenzieri A, Lacy MQ, Kyle RA, et al. Eligibility tot hemato- poietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival. J Clin Oncol, 2001, 19: 3350-3356.
  • 8Comenzo RL, Gertz MA. Autologous stem cell transplantation for primary systemic amyloidosis. Blood, 2002, 99 : 4276-4282.
  • 9Kastritis E, Anagnostopoulos A, Roussou M, et aL Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone. Haematologica, 2007, 92 : 1351-1358.
  • 10Cohen AD, Comenzo RL. Systemic light-chain amyloidosis : advances in diagnosis, prognosis, and therapy. Hematology Am Soc Hematol Educ Program ,2010,2010:287 - 294.

共引文献50

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部